Drug · DIN 02465981
DEFITELIO
ALSO KNOWN AS DEFIBROTIDE SODIUM
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 6, 2017; first marketed September 6, 2017.
- Drug Identification Number (DIN)
- 02465981
- Company (DIN owner)
- Jazz Pharmaceuticals Ireland LimitedDublin, Dublin, Ireland
- Schedule
- Prescription; Schedule d
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Defibrotide B01AX01
- Class
- Human
- Record last updated
- September 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DEFIBROTIDE | 80 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 10, 2017: NOC 19515New Drug Submission (NDS)